Mai Capital Management Ideaya Biosciences, Inc. Transaction History
Mai Capital Management
- $13.2 Billion
- Q4 2024
A detailed history of Mai Capital Management transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Mai Capital Management holds 2,250 shares of IDYA stock, worth $49,162. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,250Holding current value
$49,162% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IDYA
# of Institutions
213Shares Held
79.9MCall Options Held
39.6KPut Options Held
24.1K-
Black Rock Inc. New York, NY6.81MShares$149 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X05.86MShares$128 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$111 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA5.06MShares$111 Million0.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.87MShares$84.5 Million0.01% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.05B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...